Adenovirus-mediated p53 treatment enhances photodynamic antitumor response

Human Gene Therapy

Volumn 17, Issue 3, 2006, Pages 347-352

  Lim, Dae Seog ^a   Bae, Su Mi ^a   Kwak, Sun Young ^a   Park, Eun Kyung ^a   Kim, Jong Ki ^b   Han, Sei Jun ^c   Oh, Chung Hun ^d   Lee, Chang Hee ^e   Lee, Won Young ^f   Ahn, Woong Shick ^a  

^a The Catholic University of Korea   (South Korea)

^b Catholic University of Daegu   (South Korea)

^c Chosun University   (South Korea)

^d Dankook University   (South Korea)

^e Kangwon National University   (South Korea)

^f Yonsei University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; LIPOCORTIN 5; PROTEIN P21; PROTEIN P53; RECOMBINANT PROTEIN;

ADENOVIRUS VECTOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER TRANSPLANTATION; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG POTENCY; DRUG TUMOR LEVEL; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; PHOTODYNAMIC THERAPY; STAINING; TREATMENT OUTCOME; TUMOR CELL; VIRAL GENE THERAPY; WESTERN BLOTTING;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; COMBINED MODALITY THERAPY; FEMALE; GENE THERAPY; GENETIC VECTORS; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

ADENOVIRIDAE; ANIMALIA; MUS MUSCULUS;

EID: 33645456051     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2006.17.347     Document Type: Article

References (29)

1. ACKROYD, R., KELTY, C., BROWN, N., and REED, M. (2001). The history of photodetection and photodynamic therapy. Photochem. Photobiol. 74, 656-669.
2. AHN, W.S., BAE, S.M., LEE, J.M., NAMKOONG, S.E., YOO, J.Y., SEO, Y.S., NAM, S.L., CHO, Y.L., NAM, K.H., KIM, C.K., and KIM, Y.W. (2004). Anti-cancer effect of adenovirus p53 on human cervical cancer cell growth in vitro and in vivo. Int. J. Gynecol. Cancer 14, 322-332.
3. BAKER, S.J., MARKOWITZ, S., FEARON, E.R., WILLSON, J.K., and VOGELSTEIN, B. (1990). Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249, 912-915.
4. BERKNER, K.L. (1988). Development of adenovirus vectors for the expression of heterologous genes. Biotechniques 6, 616-629.
5. BOULIKAS, T., and VOUGIOUKA, M. (2003). Cisplatin and platinum drugs at the molecular level. Oncol. Rep. 10, 1663-1682.
6. CAI, D.W., MUKHOPADHYAY, T., LIU, Y., FUJIWARA, T., and ROTH, J.A. (1993). Stable expression of the wild-type p53 gene in human lung cancer cells after retrovirus-mediated gene transfer. Hum. Gene Ther. 4, 617-624.
7. DIXON, S.C., SORIANO, B.J., LUSH, R.M., BORNER, M.M., and FIGG, W.D. (1997). Apoptosis: Its role in the development of malignancies and its potential as a novel therapeutic target. Ann. Pharmacother. 31, 76-82.
8. DOUGHERTY, T.J. (2002). An update on photodynamic therapy applications. J. Clin. Laser Med. Surg. 20, 3-7.
9. EL-DEIRY, W.S., TORINO, T., VELCULESCU, V.E., LEVY, D.B., PARSONS, R., TRENT, J.M., LIN, D., MERCER, W.E., KINZLER, K.W., and VOGELSTEIN, B. (1993). WAF1, a potent mediator of p53 tumor suppression. Cell 75, 817-825.
10. GRAHAM, F.L., and PREVEC, L. (1995). Methods for construction of adenovirus vectors. Mol. Biotechnol. 3, 207-230.
11. HAMADA, K., ALEMANY, R., ZHANG, W.W., HITTELMAN, W.L., LOTAN, R., ROTH, J.A., and MITCHELL, M.F. (1996a). Adenovirus-mediated transfer of a wild-type 53 gene and induction of apoptosis in cervical cancer. Cancer Res. 56, 3047-3054.
12. HAMADA, K., ZHANG, W.W., ALEMANY, R., WOLF, J., ROTH, J.A., and MITCHELL, M.F. (1996b). Growth inhibition of human cervical cancer cells with the recombinant adenovirus p53 in vitro. Gynecol. Oncol. 60, 373-379.
13. HANSEN, R., and OREN, M. (1997). p53: From inductive signal to cellular effect. Curr. Opin. Genet. Dev. 7, 46-51.
14. HILDEMAN, D.A. (2004). Regulation of T-cell apoptosis by reactive oxygen species. Free Radic. Biol. Med. 36, 1496-1504.
15. KAWABE, S., MUNSHI, A., ZUMSTEIN, L.A., WILSON, D.R., ROTH, J.A., and MEYN, R.E. (2001). Adenovirus-mediated wild type p53 gene expression radiosensitizes non-small cell lung cancer cells but not normal lung fibroblasts. Int. J. Radiat. Biol. 77, 185-194.
16. KESSIS, T.D., SLEBOS, R.J. NELSON, W.G., KASTAN, M.B., PLUNKETT, B.S., HAN, S.M., LORINCZ, A.T., HEDRICK, L., and CHO, K.R. (1993). Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc. Natl. Acad. Sci. U.S.A. 90, 3988-3992.
17. KO, L.J., and PRIVES, C. (1996). p53: Puzzle and paradigm. Genes Dev. 10, 1054-1072.
18. KOHLER, M.F., MARKS, J.R., WISEMAN, R.W., JACOBS, I.J., DAVIDOFF, A.M., CLARKE-PEARSON, D.L., SOPER, J.T., BAST, R.C., Jr., and BERCHUCK, A. (1993). Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer. J. Natl. Cancer Inst. 85, 1513-1519.
19. KORZARSKY, K.F., and WILSON, J.M. (1993). Gene therapy: Adenovirus vectors. Curr. Opin. Genet. Dev. 3, 499-503.
20. KUPRYJANCZYK, J., THOR, A.D., BEAUCHAMP, R., MERRITT, V., EDGERTON, S.M., BELL, D.A., and YANDELL, D.W. (1993). p53 gene mutations and protein accumulation in human ovarian cancer. Proc. Natl. Acad. Sci. U.S.A. 90, 4961-4965.
21. LIU, T.J., ZHANG, W.W., TAYLOR, D.L., ROTH, J.A., GOEPFERT, H., and CLAYMAN, G.L. (1994). Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. Cancer Res. 54, 3662-3667.
22. MCCARTHY, J.V. (2003). Apoptosis and development. Essays Biochem. 39, 11-24.
23. NISHIZAKI, M., MEYN, R.E., LEVY, L.B., ATKINSON, E.N., WHITE, R.A., ROTH, J.A., and JI, L. (2001). Synergistic inhibition of human lung cancer cell growth by adenovirus-mediated wild type p53 gene transfer in combination with docetaxel and radiation therapeutics in vitro and in vivo. Clin. Cancer Res. 7, 2887-2897.
24. OLEINICK, N.L., MORRIS, R.L., and BELICHENKO, I. (2002). The role of apoptosis in response to photodynamic therapy: What, where, why, and how. Photochem. Photobiol. Sci. 1, 1-21.
25. PRUSCHY, M., ROCHA, S., ZAUGG, K., TENZER, A., HESS, C., FISHER, D.E., GLANZMANN, C., and BODIS, S. (2001). Key targets for the execution of radiation-induced tumor cell apoptosis: The role of p53 and caspases. Int. J. Radiat. Oncol. Biol. Phys. 49, 561-567.
26. ROTH, J.A., SWISHER S.G., and MEYN, R.E. (1999). p53 tumor suppressor gene therapy for cancer. Oncology 10, 148-154.
27. SHAO, J., FUJIWARA, T., KADOWAKI, Y., FUKAZAWA, T., WAKU, T., ITOSHIMA, T., YAMATSUJI, T., NISHIZAKI, M., ROTH, J.A., and TANAKA, N. (2000). Overexpression of the wild-type p53 gene inhibits NF-κB activity and synergizes with aspirin to induce apoptosis in human colon cancer cells. Oncogene 19, 726-736.
28. 6 derivatives on a single nerve cell. Life Sci. 74, 2185-2197.
29. WOLF, J.K., MILLS, G.B., BAZZET, L., BAST, R.C., Jr., ROTH, J.A., and GERSHENSON, D.M. (1999). Adenovirus-mediated p53 growth inhibition of ovarian cancer cells is independent of endogenous p53 status. Gynecol. Oncol. 75, 261-266.